The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses

por Murray, Sam M., Ansari, Azim M., Frater, John, Klenerman, Paul, Dunachie, Susanna, Barnes, Eleanor, Ogbe, Ane
Publicado 2022

Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir

por Wing, Peter A.C., Jones, Meleri, Cheung, Michelle, DaSilva, Sampath, Bamford, Connor, Jason Lee, Wing-Yiu, Aranday-Cortes, Elihu, Da Silva Filipe, Ana, McLauchlan, John, Smith, David, Irving, William, Cunningham, Morven, Ansari, Azim, Barnes, Eleanor, Foster, Graham R.
Publicado 2019

Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus

por Sy, Aminata, McCabe, Leanne, Hudson, Emma, Ansari, Azim M., Pedergnana, Vincent, Lin, Shang-Kuan, Santana, S., Fiorino, Marzia, Ala, Aftab, Stone, Ben, Smith, M., Nelson, Mark, Barclay, Stephen T., McPherson, Stuart, Ryder, Stephen D., Collier, Jane, Barnes, Eleanor, Walker, Ann Sarah, Pett, Sarah L., Cooke, Graham
Publicado 2023

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

por Cooke, Graham S., Pett, Sarah, McCabe, Leanne, Jones, Chris, Gilson, Richard, Verma, Sumita, Ryder, Stephen D., Collier, Jane D., Barclay, Stephen T., Ala, Aftab, Bhagani, Sanjay, Nelson, Mark, Ch'Ng, Chinlye, Stone, Ben, Wiselka, Martin, Forton, Daniel, McPherson, Stuart, Halford, Rachel, Nguyen, Dung, Smith, David, Ansari, Azim, Dennis, Emily, Hudson, Fleur, Barnes, Eleanor J., Walker, Ann Sarah
Publicado 2021